None of the companies that will be involved have a licence from the inventor of Lenacapavir, Gilead Sciences, to make the jab
The country’s medicines regulator Sahpra says it’s on track to announce its registration decision by the end of October
CAB-LA will be made at Indian drug company Cipla’s Benoni and Durban plants, but a starting date for production has not yet been announced